 AstraZeneca PLC NASDAQ:AZN Q3 2022 Earnings Conference Call November 10, 2022 6:45 AM ET Company Participants Andy Barnett - Head of Investor Relations Pascal Soriot - Executive Director and CEO Aradhana Sarin - Executive Director and CFO David Fredrickson - Executive Vice-President of Oncology Business Unit Susan Galbraith - EVP of Oncology Research Development Ruud Dobber - Executive Vice-President of BioPharmaceuticals Business Unit Menelas Pangalos - EVP of BioPharmaceuticals RD Marc Dunoyer - CEO of Alexion Leon Wang - EVP of International China President Iskra Reic - EVP, Vaccines and Immune Therapies Conference Call Participants Simon Baker - Redburn Sachin Jain - BofA Securities Andrew Baum - Citi Timothy Anderson - Wolfe Research Mark Purcell - Morgan Stanley Stephen Scala - Cowen and Company James Gordon - JPMorgan Richard Parkes - BNP Paribas Exane Eric Le Berrigaud - Stifel Michael Leuchten - UBS Jo Walton - Credit Suisse Emmanuel Papadakis - Deutsche Bank Seamus Fernandez - Guggenheim Peter Welford - Jefferies Adam Karlsson - ABG Sundal Collier Luisa Hector - Berenberg Operator Good morning to those joining from the U.K. and the U.S., good afternoon to those in Central Europe, and good evening to those listening in Asia. Welcome, ladies and gentlemen, to AstraZenecas Year-to-date and Q3 Results 2022 Conference Call for Investors and Analysts. 